Remedy Robotics Secures $62 Million In Series B Funding Led By DCVC
San Francisco-based Remedy Robotics, a healthcare and physical AI company developing robotic systems for cardiovascular and endovascular procedures, raised $62 million in Series B funding in a round led by DCVC, with…
San Francisco-based Remedy Robotics, a healthcare and physical AI company developing robotic systems for cardiovascular and endovascular procedures, raised $62 million in Series B funding in a round led by DCVC, with participation from UC Investments, Skip Capital, Hostplus, Build Collective by Tony Fadell, Blackbird, Divergent Capital and KdT Ventures. Co-founded by CEO Dr. David Bell and CTO Jake Sganga, the company develops the N1 System, an AI-enabled robotic platform designed to support remote, on-site and autonomous vascular procedures. Remedy Robotics will use the funding to accelerate a pivotal clinical trial with the University of California, advance toward FDA approval for neurovascular intervention, deploy prototype N1 Systems across its clinical partner network and further develop its AI and autonomous capabilities.
FOUNDERS: Dr. David Bell & Jake Sganga
INVESTORS: DCVC, UC Investments, Skip Capital, Hostplus, Build Collective by Tony Fadell, Blackbird, Divergent Capital, KdT Ventures
ROUND: Series B AMOUNT: $62,000,000
HQ: San Francisco, California
#VentureCapital #RemedyRobotics #DrDavidBell #JakeSganga #TradedVC
ABOUT THE DEAL
- Raise
- $62M
- Round
- Series B
- Company
- Remedy Robotics
- Desk
- Deals
- Filed
- Nov 16, 2026
- Founders
- Dr. David Bell
- Jake Sganga
- Investors
- DCVC
- UC Investments
- Skip Capital
- Hostplus
- Build Collective by Tony Fadell
- Blackbird
- Divergent Capital
- KdT Ventures
More deals
ALL DEALSBetterness Secures $1 Million In Seed Extension Funding To Expand Health Network
Nov 16, 2026
Ardian Semiconductor Raises €1 Billion For Private Equity Strategy In Semiconductor Value Chain
Nov 16, 2026
Serena Williams Launches Starfire Ventures With $200 Million Fund For Startups
Nov 16, 2026